Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2025-12-24 @ 7:39 PM
NCT ID:
NCT00442403
Eligibility Criteria:
Inclusion Criteria:
* signing an informed consent (informed consent was given by legal guardian for children);
* age egal or more than 15 years;
* fever (axillary temperature egal or more than 37.5 °C and less than 40°C) or a history of fever within the last 24 hours;
* no sign suggestive of other febrile illness;
* absence of signs of complicated malaria (WHO criteria);
* willingness to participate in follow-up for 14 days
* a positive thick blood film for P. falciparum without other detectable infectious microorganisms
Exclusion Criteria:
* patients taking glucocorticoids or other immuno-suppressive drugs, or indicating recent antimalarial drug history (verbal questionnaire);
* severe malaria;
* mixed infections;
* women using contraceptives;
* pregnant women;
* breast-feeding women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT00442403
Study Brief:
Protocol Section:
NCT00442403